Detalhe da pesquisa
1.
Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives.
Clin Microbiol Rev
; 31(4)2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30158301
2.
[Estimating demand for anti-Chagas drugs: a contribution for access in Latin America]. / Estimación de la demanda de medicamentos antichagásicos: una contribución para el acceso en América Latina.
Rev Panam Salud Publica
; 41: e45, 2017 Jun 08.
Artigo
em Espanhol
| MEDLINE | ID: mdl-28614468
3.
Cutaneous leishmaniasis treatment and therapeutic outcomes in special populations: A collaborative retrospective study.
PLoS Negl Trop Dis
; 17(1): e0011029, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36689465
4.
A phase II multicenter randomized study to evaluate the safety and efficacy of combining thermotherapy and a short course of miltefosine for the treatment of uncomplicated cutaneous leishmaniasis in the New World.
PLoS Negl Trop Dis
; 16(3): e0010238, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35255096
5.
In Vitro Susceptibility to Miltefosine of Leishmania infantum (syn. L. chagasi) Isolates from Different Geographical Areas in Brazil.
Microorganisms
; 9(6)2021 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34198947
6.
Harmonized clinical trial methodologies for localized cutaneous leishmaniasis and potential for extensive network with capacities for clinical evaluation.
PLoS Negl Trop Dis
; 12(1): e0006141, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29329311
7.
Efficacy and safety of available treatments for visceral leishmaniasis in Brazil: A multicenter, randomized, open label trial.
PLoS Negl Trop Dis
; 11(6): e0005706, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28662034